HER2-positive | World Briefings
Advertise with us
Subscribe
Subscribe to World Briefings's newsletter

News Updates

Let's join our newsletter!

Do not worry we don't spam!

HER2-positive

Explore All HER2-positive News and Updates Here
Jazz Pharmaceuticals Reports Encouraging 30-Month Survival Data for Zanidatamab in Gastric Cancer

World

17 Sep, 2024
Maria Garcia

Jazz Pharmaceuticals Reports Encouraging 30-Month Survival Data for Zanidatamab in Gastric Cancer

Jazz Pharmaceuticals has posted fresh phase 2 data on zanidatamab that show the HER2-targeted bispecific antibody kept 59% of people...

News Categories
Follow Us
Newsletter
Subscribe to Newsletter

Stay Tuned With Updates